Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02611050 · ClinicalTrials.gov registry record · NA
Treatment Decisions for Multi-vessel CAD
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Terminated
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT02611050: Clinical Trial NA study, sponsored by Dartmouth-Hitchcock Medical Center.
NCT02611050 is a NA study that was terminated before completion, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02611050, a NA study, was terminated before completion, sponsored by Dartmouth-Hitchcock Medical Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study is a multi-center randomized trial to evaluate the Multi-vessel Coronary Artery Disease Option Grid patient decision aid compared to usual care in patient reported decisional conflict, knowledge, and shared decision making.
Primary Outcome
The Ottawa Decisional Conflict Scale is a validated measure of a patient's feeling of conflict with the decision making experience
Interventions
- BEHAVIORAL Usual Care
- BEHAVIORAL The Multi-vessel Coronary Artery Disease Option Grid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2015-09-20 |
| Est. Completion | 2017-05-31 |
| Phase | NA |
Why NCT02611050 stopped before completion
NCT02611050 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Usual Care is the first listed.
NCT02611050 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02611050 about?
NCT02611050 is a clinical study titled "Treatment Decisions for Multi-vessel CAD". This study is a multi-center randomized trial to evaluate the Multi-vessel Coronary Artery Disease Option Grid patient decision aid compared to usual care in patient reported decisional conflict, knowledge, and shared decision making.
What is the current status of trial NCT02611050?
This trial is currently terminated. It is a NA study. The enrollment target is 14 participants. The study started on 2015-09-20. Estimated completion is 2017-05-31.
What interventions are being tested in trial NCT02611050?
The interventions under investigation include: Usual Care (BEHAVIORAL), The Multi-vessel Coronary Artery Disease Option Grid (BEHAVIORAL).
Who is sponsoring clinical trial NCT02611050?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02611050's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy